肝硬化合并急性消化性溃疡出血与静脉曲张出血患者在当前一线治疗下的生存比较
这项多中心队列研究连续纳入肝硬化急性消化道出血患者,入院即予生长抑素、质子泵抑制剂输注及抗生素预防,6小时内急诊内镜治疗。共646例静脉曲张出血与144例消化性溃疡出血患者,两组45天死亡率相似(19% vs 17%;OR=0.85;95%CI=0.55-1.33;P=0.48),静脉曲张出血组再出血更频繁(18% vs 10%;OR=0.50;95%CI=0.29-0.88)。
要点
- 肝硬化合并急性消化性溃疡出血与静脉曲张出血的45天死亡率相似(19% vs 17%;OR=0.85;95%CI=0.55-1.33;P=0.48)。
- 静脉曲张出血组再出血更频繁(18% vs 10%;OR=0.50;95%CI=0.29-0.88)。
- 两组死于未控制出血者少(溃疡组2% vs 静脉曲张组3%;P=0.39),多死于肝衰竭或合并症。
核心结论
- 采用当前一线治疗,肝硬化合并急性消化性溃疡出血患者的生存与静脉曲张出血患者相似。
- 静脉曲张出血患者再出血风险更高,但两组因未控制出血死亡者均少,死亡原因通常与肝衰竭或合并症相关。
研究设计与样本
- 多中心队列研究,连续纳入肝硬化急性消化道出血患者,入院即予生长抑素和质子泵抑制剂输注及抗生素预防,6小时内行急诊内镜及内镜治疗。
- 共纳入646例急性静脉曲张出血患者和144例消化性溃疡出血患者。
主要发现
- 两组基线存在差异,如胃侵蚀性药物或β受体阻滞剂使用;Child-Pugh评分和终末期肝病模型(MELD)评分相似。
- 静脉曲张出血组再出血较消化性溃疡出血组更频繁(18% vs 10%;OR=0.50;95%CI=0.29-0.88)。
- 45天死亡风险两组相似(静脉曲张出血组19% vs 消化性溃疡出血组17%;OR=0.85;95%CI=0.55-1.33;P=0.48)。
- Child-Pugh评分、急性肾损伤、慢加急性肝衰竭、休克或细菌感染存在等参数与死亡风险相关,而出血原因与死亡风险无关。
- 消化性溃疡出血组2% vs 静脉曲张出血组3%死于未控制出血(P=0.39),两组多数患者死于肝衰竭或其他合并症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The presence of cirrhosis increases the mortality of patients with peptic ulcer bleeding (PUB). Both acute variceal bleeding (AVB) and PUB are associated with substantial mortality in cirrhosis. This multicenter cohort study was performed to assess whether the mortality of patients with cirrhosis with PUB is different from that of those with AVB. Patients with cirrhosis and acute gastrointestinal bleeding were consecutively included and treated with somatostatin and proton pump inhibitor infusion from admission and with antibiotic prophylaxis. Emergency endoscopy with endoscopic therapy was performed within the first 6 hours. 646 patients with AVB and 144 with PUB were included. There were baseline differences between groups, such as use of gastroerosive drugs or β-blockers. Child-Pugh and Model for End-Stage Liver Disease MELD scores were similar. Further bleeding was more frequent in the AVB group than those in the PUB group (18% vs. 10%; odds ratio [OR] = 0.50; 95% confidence interval [CI] = 0.29-0.88). However, mortality risk at 45 days was similar in both groups (19% in the AVB group vs. 17% in the PUB group; OR = 0.85; 95% CI = 0.55-1.33; P = 0.48). Different parameters, such as Child-Pugh score, acute kidney injury, acute on chronic liver failure, or presence of shock or bacterial infection, but not the cause of bleeding, were related to the risk of death. Only 2% of the PUB group versus 3% of the AVB group died with uncontrolled bleeding (P = 0.39), whereas the majority of patients in either group died from liver failure or attributed to other comorbidities. CONCLUSION: Using current first-line therapy, patients with cirrhosis and acute peptic ulcer bleeding have a similar survival than those with variceal bleeding. The risk of further bleeding is higher in patients with variceal hemorrhage. However, few patients in both groups died from uncontrolled bleeding, rather the cause of death was usually related to liver failure or comorbidities. (Hepatology 2018;67:1458-1471).
引用
- Ardevol A, Ibañez-Sanz G, Profitos J, et al. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies. Hepatology. 2018. PMID: 28714072. doi:10.1002/hep.29370
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。